Interruzione della terapia di mantenimento per la meningite criptococcica in pazienti con AIDS trattati con HAART

Translated title of the contribution: Discontinuation of maintenance therapy for cryptococcal meningitis in HIV-1-infected persons receiving highly active antiretroviral therapy

Cristina Mussini, Andrea Bedini, Patrizio Pezzotti, Vanni Borghi, Stefania Casolari, Andrea Antinori, Alessandra Govoni, Patrizia Ortolani, Giuliano Rizzardini, Andrea De Luca, Nicola Mongiardo, Andrea Cossarizza, Roberto Esposito

Research output: Contribution to journalArticle

Abstract

Background. Little is known on whether HIV-infected persons with cryptococcal meningitis can discontinue maintenance therapy following HAART-induced immune-reconstitution. The present study is a longitudinal multicentre observational study which aims to determine the incidence of relapses of cryptococcal meningitis among persons undergoing HAART. Methods. The study was conducted by reviewing the clinical charts of HIV-positive adults who had ever attended, as consecutive outpatients, 10 hospital-based infectious-disease clinics located throughout Italy. We included all of the persons who had recovered from at least one episode of cryptococcal meningitis, and who were currently undergoing HAART. The study group consisted of those persons who had discontinued maintenance therapy for cryptococcal meningitis; the, control group consisted of those persons who were still undergoing maintenance therapy. Of the 45 study participants, 24 had discontinued maintenance therapy and 21 had continued. At the time of discontinuation, for the discontinuing participants, the mean CD4 cell count was 113.5 cells/mL, although 12 (50.0%) of them had less than 100 cells/mL; the mean plasma viral load was 2.48 log10 copies/mL; and 12 of them (50.0%) were seropositive for cryptococcal antigen. Results. At the end of the observation period, for the discontinuing participants, the mean CD4 count was 330 cells/mL (compared to 240 cells/mL for the continuing participants); the mean plasma viral load was 2.34 log10 copies/mL (compared to

Original languageItalian
Pages (from-to)227-236
Number of pages10
JournalRivista di Neurobiologia
Volume47
Issue number3
Publication statusPublished - 2001

Fingerprint

Cryptococcal Meningitis
Highly Active Antiretroviral Therapy
HIV-1
CD4 Lymphocyte Count
Viral Load
HIV
Therapeutics
Italy
Multicenter Studies
Observational Studies
Communicable Diseases
Outpatients
Observation
Antigens
Recurrence
Control Groups
Incidence

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Mussini, C., Bedini, A., Pezzotti, P., Borghi, V., Casolari, S., Antinori, A., ... Esposito, R. (2001). Interruzione della terapia di mantenimento per la meningite criptococcica in pazienti con AIDS trattati con HAART. Rivista di Neurobiologia, 47(3), 227-236.

Interruzione della terapia di mantenimento per la meningite criptococcica in pazienti con AIDS trattati con HAART. / Mussini, Cristina; Bedini, Andrea; Pezzotti, Patrizio; Borghi, Vanni; Casolari, Stefania; Antinori, Andrea; Govoni, Alessandra; Ortolani, Patrizia; Rizzardini, Giuliano; De Luca, Andrea; Mongiardo, Nicola; Cossarizza, Andrea; Esposito, Roberto.

In: Rivista di Neurobiologia, Vol. 47, No. 3, 2001, p. 227-236.

Research output: Contribution to journalArticle

Mussini, C, Bedini, A, Pezzotti, P, Borghi, V, Casolari, S, Antinori, A, Govoni, A, Ortolani, P, Rizzardini, G, De Luca, A, Mongiardo, N, Cossarizza, A & Esposito, R 2001, 'Interruzione della terapia di mantenimento per la meningite criptococcica in pazienti con AIDS trattati con HAART', Rivista di Neurobiologia, vol. 47, no. 3, pp. 227-236.
Mussini, Cristina ; Bedini, Andrea ; Pezzotti, Patrizio ; Borghi, Vanni ; Casolari, Stefania ; Antinori, Andrea ; Govoni, Alessandra ; Ortolani, Patrizia ; Rizzardini, Giuliano ; De Luca, Andrea ; Mongiardo, Nicola ; Cossarizza, Andrea ; Esposito, Roberto. / Interruzione della terapia di mantenimento per la meningite criptococcica in pazienti con AIDS trattati con HAART. In: Rivista di Neurobiologia. 2001 ; Vol. 47, No. 3. pp. 227-236.
@article{46d3a4695b5b43fe9b892559d563aa53,
title = "Interruzione della terapia di mantenimento per la meningite criptococcica in pazienti con AIDS trattati con HAART",
abstract = "Background. Little is known on whether HIV-infected persons with cryptococcal meningitis can discontinue maintenance therapy following HAART-induced immune-reconstitution. The present study is a longitudinal multicentre observational study which aims to determine the incidence of relapses of cryptococcal meningitis among persons undergoing HAART. Methods. The study was conducted by reviewing the clinical charts of HIV-positive adults who had ever attended, as consecutive outpatients, 10 hospital-based infectious-disease clinics located throughout Italy. We included all of the persons who had recovered from at least one episode of cryptococcal meningitis, and who were currently undergoing HAART. The study group consisted of those persons who had discontinued maintenance therapy for cryptococcal meningitis; the, control group consisted of those persons who were still undergoing maintenance therapy. Of the 45 study participants, 24 had discontinued maintenance therapy and 21 had continued. At the time of discontinuation, for the discontinuing participants, the mean CD4 cell count was 113.5 cells/mL, although 12 (50.0{\%}) of them had less than 100 cells/mL; the mean plasma viral load was 2.48 log10 copies/mL; and 12 of them (50.0{\%}) were seropositive for cryptococcal antigen. Results. At the end of the observation period, for the discontinuing participants, the mean CD4 count was 330 cells/mL (compared to 240 cells/mL for the continuing participants); the mean plasma viral load was 2.34 log10 copies/mL (compared to",
keywords = "Cryptococcal meningitis, HAART (High Active Antiretroviral Therapy), Maintenance therapy",
author = "Cristina Mussini and Andrea Bedini and Patrizio Pezzotti and Vanni Borghi and Stefania Casolari and Andrea Antinori and Alessandra Govoni and Patrizia Ortolani and Giuliano Rizzardini and {De Luca}, Andrea and Nicola Mongiardo and Andrea Cossarizza and Roberto Esposito",
year = "2001",
language = "Italian",
volume = "47",
pages = "227--236",
journal = "Rivista Italiana di Neurobiologia",
issn = "0035-6336",
publisher = "Editrice Pisani s.a.s.",
number = "3",

}

TY - JOUR

T1 - Interruzione della terapia di mantenimento per la meningite criptococcica in pazienti con AIDS trattati con HAART

AU - Mussini, Cristina

AU - Bedini, Andrea

AU - Pezzotti, Patrizio

AU - Borghi, Vanni

AU - Casolari, Stefania

AU - Antinori, Andrea

AU - Govoni, Alessandra

AU - Ortolani, Patrizia

AU - Rizzardini, Giuliano

AU - De Luca, Andrea

AU - Mongiardo, Nicola

AU - Cossarizza, Andrea

AU - Esposito, Roberto

PY - 2001

Y1 - 2001

N2 - Background. Little is known on whether HIV-infected persons with cryptococcal meningitis can discontinue maintenance therapy following HAART-induced immune-reconstitution. The present study is a longitudinal multicentre observational study which aims to determine the incidence of relapses of cryptococcal meningitis among persons undergoing HAART. Methods. The study was conducted by reviewing the clinical charts of HIV-positive adults who had ever attended, as consecutive outpatients, 10 hospital-based infectious-disease clinics located throughout Italy. We included all of the persons who had recovered from at least one episode of cryptococcal meningitis, and who were currently undergoing HAART. The study group consisted of those persons who had discontinued maintenance therapy for cryptococcal meningitis; the, control group consisted of those persons who were still undergoing maintenance therapy. Of the 45 study participants, 24 had discontinued maintenance therapy and 21 had continued. At the time of discontinuation, for the discontinuing participants, the mean CD4 cell count was 113.5 cells/mL, although 12 (50.0%) of them had less than 100 cells/mL; the mean plasma viral load was 2.48 log10 copies/mL; and 12 of them (50.0%) were seropositive for cryptococcal antigen. Results. At the end of the observation period, for the discontinuing participants, the mean CD4 count was 330 cells/mL (compared to 240 cells/mL for the continuing participants); the mean plasma viral load was 2.34 log10 copies/mL (compared to

AB - Background. Little is known on whether HIV-infected persons with cryptococcal meningitis can discontinue maintenance therapy following HAART-induced immune-reconstitution. The present study is a longitudinal multicentre observational study which aims to determine the incidence of relapses of cryptococcal meningitis among persons undergoing HAART. Methods. The study was conducted by reviewing the clinical charts of HIV-positive adults who had ever attended, as consecutive outpatients, 10 hospital-based infectious-disease clinics located throughout Italy. We included all of the persons who had recovered from at least one episode of cryptococcal meningitis, and who were currently undergoing HAART. The study group consisted of those persons who had discontinued maintenance therapy for cryptococcal meningitis; the, control group consisted of those persons who were still undergoing maintenance therapy. Of the 45 study participants, 24 had discontinued maintenance therapy and 21 had continued. At the time of discontinuation, for the discontinuing participants, the mean CD4 cell count was 113.5 cells/mL, although 12 (50.0%) of them had less than 100 cells/mL; the mean plasma viral load was 2.48 log10 copies/mL; and 12 of them (50.0%) were seropositive for cryptococcal antigen. Results. At the end of the observation period, for the discontinuing participants, the mean CD4 count was 330 cells/mL (compared to 240 cells/mL for the continuing participants); the mean plasma viral load was 2.34 log10 copies/mL (compared to

KW - Cryptococcal meningitis

KW - HAART (High Active Antiretroviral Therapy)

KW - Maintenance therapy

UR - http://www.scopus.com/inward/record.url?scp=0035735033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035735033&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0035735033

VL - 47

SP - 227

EP - 236

JO - Rivista Italiana di Neurobiologia

JF - Rivista Italiana di Neurobiologia

SN - 0035-6336

IS - 3

ER -